Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

NCT06109831 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemic

Interventions

DRUG: SHR-1918
DRUG: SHR-1918 placebo

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd